You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Cline Christopher R. · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$42.61K
Cline Christopher R. Chief Financial Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
TVTX daily price context
Close on/before transaction
$67.23
Sep 2, 2026
First close after public filing
$65.28
Sep 4, 2026
30-day return after filing
-11.66%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 642 shares @ $66.37
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001943192-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$42.61K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 2, 2026 | $42.61K |